Company / Revenue
Kura Oncology, Inc. Revenue History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$67.5M
FY2025
5-year range
$53.9M / $67.5M
FY2024-FY2025
Trend
+25.2%
vs FY2024
Sector context
#115 of 155
Health Care
What the data says
At $67M, Kura Oncology, Inc.'s revenue ranks #115 of 155 in the Health Care sector.
Based on SEC 10-K filings.
$67M in FY2025.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 155 in Health CareTop 74% of 155This company $67.5M Sector average $4.5B
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2025, revenue increased 25.2% year-over-year.
- Ranks #115 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.5M | +25.2% |
| FY2024 | $53.9M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026